Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
18.53
+0.19 (1.04%)
Oct 9, 2026, 2:21 PM EDT - Market open
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $2.1 billion as of October 9, 2026. It is the 6,588th most valuable company in the world and the 1,747th biggest in the United States. Its market cap has increased by 20.35% in one year.
Market Cap
2.10B
Enterprise Value
1.36B
1-Year Change
20.35%
Global Rank
Country Rank
#1,747 United States
Category
ChartMarket Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $2.10B, an increase of 5,949.87%. That is a compound annual growth rate of 39.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.10B | -29.32% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.22B |
| Immunome | 2.18B |
| Vera Therapeutics | 2.17B |
| Aurinia Pharmaceuticals | 2.14B |
| Vericel | 2.11B |
| ADARx Pharmaceuticals | 2.03B |
| UroGen Pharma | 2.02B |
| Lakefront Biotherapeutics NV | 1.97B |